	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	87.34	109.10	118.32	107.25	124.71	153.85	183.45	212.64	180.71	210.68	278.28	318.19	288.59	344.17	407.69
Cost of Operating Revenue	57.67	58.43	51.06	47.13	56.19	60.33	68.70	54.59	53.70	61.31	78.40	74.96	68.03	79.19	97.67
Gross Profit	29.67	50.67	67.26	60.12	68.52	93.52	114.75	158.06	127.01	149.37	199.88	243.23	220.56	264.98	310.02
Gross Margin	34.0	46.4	56.8	56.1	54.9	60.8	62.6	74.3	70.3	70.9	71.8	76.4	76.4	77.0	76.0
Total Operating Expenses	102.21	103.35	101.55	100.93	116.10	136.17	153.88	174.59	171.69	180.35	221.10	253.99	227.70	257.32	309.38
Operating Profit	-14.86	5.75	16.76	6.32	8.61	17.68	29.57	38.05	9.02	30.33	57.18	64.20	60.90	86.84	98.31
Operating Margin	-17.0	5.3	14.2	5.9	6.9	11.5	16.1	17.9	5.0	14.4	20.5	20.2	21.1	25.2	24.1
Financing Income/(Expense) - Net	-3.67	-2.49	0.20	-0.19	-1.30	-2.09	-5.20	-3.07	-1.82	-2.19	-1.59	-2.60	-0.50	0.29	4.88
Profit before Taxes	-15.98	4.37	17.66	6.64	8.35	16.54	25.56	35.14	8.27	28.54	55.69	65.00	62.50	89.00	103.95
Income Taxes	-0.60	0.16	4.42	1.58	1.92	5.94	9.13	9.83	1.43	7.13	14.36	16.82	13.69	22.24	26.44
Profit after Tax	-15.38	4.21	13.24	5.06	6.43	10.59	16.43	25.31	6.85	21.41	41.33	48.17	41.01	67.34	77.51
PAT Margin	-17.6	3.9	11.2	4.7	5.2	6.9	9.0	11.9	3.8	10.2	14.9	15.1	14.2	19.6	19.0
EPS - Basic - ex Extraordinary Items	-3.48	0.95	2.99	1.14	1.46	2.40	3.72	5.72	1.55	4.84	9.35	10.88	11.02	15.01	17.40
EPS - Diluted - ex Extraordinary Items	-3.48	0.95	2.99	1.14	1.46	2.40	3.72	5.72	1.55	4.84	9.16	10.68	10.86	14.80	17.20
EBIT	-14.86	5.75	16.76	6.32	8.61	17.68	29.57	38.05	9.02	30.33	57.18	64.20	60.90	86.84	98.31
EBITDA	1.00	20.75	26.15	17.42	18.87	27.31	45.27	57.77	29.95	53.40	80.51	94.91	60.93	122.13	142.08
EBITDA Margin	1.1	19.0	22.1	16.2	15.1	17.8	24.7	27.2	16.6	25.3	28.9	29.8	21.1	35.5	34.9

Balance Sheet

Abridged

Understanding Balance Sheet

Vimta Labs Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	41.43	47.55	53.46	56.70	62.49	69.83	83.56	92.32	95.86	110.54	124.36	163.66	157.60	187.82	224.87
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	2.50	3.07	-	-	5.00
Property Plant & Equipment - Net	105.04	93.57	92.39	88.21	93.58	141.22	140.39	138.90	134.21	146.63	150.08	169.33	215.02	261.67	318.19
Total Non-Current Assets	115.00	97.06	95.57	89.65	113.38	151.82	148.69	145.11	149.83	163.82	182.84	198.67	236.87	278.72	337.36
Total Assets	156.42	144.61	149.03	146.35	175.86	221.65	232.26	237.43	245.69	274.36	307.20	362.32	394.47	466.53	562.23
Total Current Liabilities	44.83	31.09	26.73	20.78	28.53	59.44	49.83	43.30	57.56	53.91	47.75	57.28	54.07	64.37	65.52
Long Term Debt	-	-	-	-	14.25	18.08	19.46	11.57	5.38	14.24	12.66	9.89	9.07	3.22	1.56
Total Non-Current Liabilities	1.94	1.19	1.91	3.23	18.57	26.06	30.37	22.57	15.25	26.06	25.46	23.26	26.28	23.32	39.83
Total Liabilities	46.77	32.28	28.64	24.02	47.10	85.50	80.20	65.88	72.82	79.97	73.21	80.54	80.35	87.68	105.35
Total Shareholders' Equity	109.65	112.32	120.39	122.33	128.77	136.15	152.05	171.55	172.88	194.38	233.98	281.79	314.12	378.85	456.87
Total Equity	109.65	112.32	120.39	122.33	128.77	136.15	152.05	171.55	172.88	194.38	233.98	281.79	314.12	378.85	456.87
Total Liabilities & Equity	156.42	144.61	149.03	146.35	175.86	221.65	232.26	237.43	245.69	274.36	307.20	362.32	394.47	466.53	562.23

Cash Flow

Abridged

Understanding Cash Flow Statement

Vimta Labs Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1.32	17.72	23.14	16.35	17.71	22.14	38.77	52.88	23.88	49.50	67.60	91.66	76.29	102.60	132.51
Working Capital - Increase/(Decrease)	8.04	-4.58	-8.21	-1.46	-19.57	0.63	-9.14	-16.08	-1.35	-13.64	-8.46	-3.64	-15.38	-7.99	16.16
Net CF from Operating Activities	9.36	13.14	14.93	14.89	-1.86	22.77	29.62	36.80	22.53	35.86	59.14	88.02	60.91	94.61	148.66
Capital Expenditures - Net	3.86	3.54	8.28	7.62	15.55	39.83	24.32	16.32	15.28	32.89	38.68	49.56	74.48	76.62	99.71
Net CF from Investing Activities	-3.86	-3.54	-8.28	-7.62	-15.55	-39.88	-24.32	-16.37	-21.35	-32.32	-38.70	-58.22	-77.55	-76.86	-131.70
Dividends Paid - Cash - Total	1.03	-	1.54	5.17	2.65	2.66	-	5.33	5.33	-	4.42	4.42	4.43	4.43	4.45
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-	-	-	0.00	0.01	0.01	0.04
Debt - LT & ST - Issuance/(Retirement) - Total	-4.66	-8.97	-5.07	-3.05	22.47	17.51	-3.93	-14.43	6.99	-2.84	-11.42	-5.68	4.00	-10.93	-5.43
Net Cash Flow from Financing Activities	-5.69	-8.97	-6.61	-8.23	19.81	14.85	-3.93	-19.76	1.66	-2.84	-15.84	-10.10	-0.42	-15.35	-9.84
Free Cash Flow to Equity	0.84	0.63	1.58	4.21	5.06	0.45	1.36	6.05	14.24	0.12	9.04	32.78	-9.57	7.06	43.52
Free Operating CF net dividend	4.46	9.21	4.73	2.09	-20.20	-19.78	5.28	14.94	1.41	2.77	16.00	33.79	-20.09	10.68	44.41
Free Operating CF	5.49	9.21	6.27	7.26	-17.55	-17.12	5.28	20.27	6.73	2.77	20.42	38.21	-15.66	15.11	48.86

Business Segment Analysis

FY End:

Mar 26

Vimta Labs Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

contract research and testing services (100.0%)₹ 99.80 Cr

Revenue / Sales

contract research and testing services (100.0%)₹ 407.69 Cr

Assets

contract research and testing services (100.0%)₹ 562.23 Cr

Operating Income

contract research and testing services (100.0%)₹ 98.31 Cr

Regional Segment Analysis

Vimta Labs Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Vimta Labs Ltd.

Historical Segment Analysis

Track how Vimta Labs Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

contract research and testing services	16	33	39	50	77	79	100

Frequently Asked Questions

What is the revenue of Vimta Labs Ltd.?

The latest trailing twelve month revenue of Vimta Labs Ltd. is ₹ 407.29 Cr, reflecting a 1-year growth of 18.34% and a 3-year CAGR of 8.58%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Vimta Labs Ltd.?

The latest trailing twelve month net profit (PAT) of Vimta Labs Ltd. is ₹ 77.51 Cr, with a 3-year earnings CAGR of 17.23%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Vimta Labs Ltd.?

The trailing twelve month EBITDA of Vimta Labs Ltd. is approximately ₹ 97.75 Cr (based on an operating margin of 24.00%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Vimta Labs Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Vimta Labs Ltd. is 17.20. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Vimta Labs Ltd.?

The debt-to-equity ratio of Vimta Labs Ltd. stands at 0.01. The interest coverage ratio is 83.76x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Vimta Labs Ltd.?

The estimated book value per share of Vimta Labs Ltd. is 102.24 (derived from a P/B ratio of 5.26 and market price of ₹ 537.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Vimta Labs Ltd.?

The trailing twelve month operating cash flow of Vimta Labs Ltd. is ₹ 148.66 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Vimta Labs Ltd. report consolidated or standalone financials?

Vimta Labs Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.